Pet Relaxants Market

Pet Relaxants Market Forecast and Outlook (2025-2035)

The global pet relaxants market is projected to reach USD 1,200 million by 2035, recording an absolute increase of USD 440.0 million over the forecast period. The market is valued at USD 760 million in 2025 and is set to rise at a CAGR of 4.7% during the assessment period. The overall market size is expected to grow by nearly 1.6 times during the same period, supported by increasing pet ownership and awareness of pet mental health worldwide, driving demand for natural calming solutions and increasing investments in pet healthcare and wellness products globally. However, varying regulatory standards for pet supplements and complex formulation requirements may pose challenges to market expansion.

Quick Stats for Pet Relaxants Market

• Pet Relaxants Market Value (2025): USD 760 million
• Pet Relaxants Market Forecast Value (2035): USD 1,200 million
• Pet Relaxants Market Forecast CAGR: 4.7%
• Leading Form in Pet Relaxants Market: Chews
• Key Growth Regions in Pet Relaxants Market: North America, Europe, and Asia Pacific

• Top Players in Pet Relaxants Market: Zesty Paws, Pet Naturals, Vetoquinol, Nestlé Purina, Nutramax, VetriScience, Bark&Spark, Thorne Pets, Pet Wellbeing, Virbac, Ark Naturals, PetNC, Honest Paws, Zoetis, Calm Paws

Pet Relaxants Market Year-over-Year Forecast (2025-2035)

Between 2025 and 2030, the pet relaxants market is projected to expand from USD 760 million to USD 961.0 million, resulting in a value increase of USD 201.0 million, which represents 45.7% of the total forecast growth for the decade. This phase of development will be shaped by rising demand for natural pet wellness solutions and specialized anxiety management products, product innovation in herbal formulations and targeted delivery systems, as well as expanding integration with modern veterinary practices and pet care technologies. Companies are establishing competitive positions through investment in research capabilities, natural ingredient sourcing technologies, and strategic market expansion across dog, cat, and specialty pet applications.

From 2030 to 2035, the market is forecast to grow from USD 961.0 million to USD 1,200 million, adding another USD 239.0 million, which constitutes 54.3% of the overall ten-year expansion. This period is expected to be characterized by the expansion of specialized formulation approaches, including advanced delivery systems and integrated wellness solutions tailored for specific pet behavioral requirements, strategic collaborations between manufacturers and veterinary professionals, and an enhanced focus on regulatory harmonization and standardized efficacy testing. The growing emphasis on preventive pet healthcare and comprehensive wellness solutions will drive demand for comprehensive relaxation systems across diverse pet care applications.

Pet Relaxants Market Key Takeaways

Metric	Value
Market Value (2025)	USD 760 million
Market Forecast Value (2035)	USD 1,200 million
Forecast CAGR (2025-2035)	4.7%

Why is the Pet Relaxants Market Growing?

The pet relaxants market grows by enabling pet owners and veterinary professionals to address behavioral challenges while accessing natural calming technologies without requiring prescription medications. Pet owners and animal care facilities face mounting pressure to manage pet anxiety and behavioral issues with safe alternatives, with specialized relaxation products typically providing 80-90% effectiveness comparable to pharmaceutical alternatives, making natural solutions essential for comprehensive pet care positioning. The pet care industry's need for versatile calming solutions and behavior-specific management control creates demand for comprehensive relaxant systems that can provide superior anxiety relief, maintain consistent performance, and ensure safety compliance without compromising pet health standards or treatment requirements.

Government initiatives promoting natural pet healthcare practices and non-pharmaceutical wellness solutions drive adoption in companion animal, professional care, and specialty applications, where product effectiveness has a direct impact on pet wellbeing and behavioral improvement. However, formulation complexity constraints during development phases and the expertise requirements for specialized ingredient deployment may limit accessibility among smaller manufacturers and developing regions with limited technical infrastructure for advanced pet supplement production systems.

Segmental Analysis

The market is segmented by form, pet type, channel, and region. By form, the market is divided into chews, drops/sprays, and tablets. Based on pet type, the market is categorized into dog, cat, and others. By channel, the market includes online and retail. Regionally, the market is divided into North America, Europe, Asia Pacific, and other key regions.

By Form, the Chews Segment Accounts for a Dominant Market Share

The chews segment represents the dominant force in the pet relaxants market, capturing approximately 50% of total market share in 2025. This established delivery category encompasses solutions featuring sophisticated palatability formulations and convenient administration methods, including advanced flavor combinations and specialized textures that enable superior pet acceptance and dosing performance across all behavioral conditions. The chews segment's market leadership stems from its superior convenience capabilities, with products capable of handling diverse pet preferences while maintaining consistent efficacy standards and operational reliability across all pet environments.

The drops/sprays segment maintains a substantial 30.0% market share, serving pet care applications that require rapid onset action with enhanced flexibility features for complex behavioral conditions and specialized anxiety management. These products offer premium delivery solutions for acute stress situations while providing sufficient versatility capabilities to meet regulatory quality control and safety demands. The tablets segment accounts for approximately 20.0% of the market, serving specialized veterinary applications.

Key technological advantages driving the chews segment include:

• Advanced palatability technologies with integrated flavor systems that reduce administration complexity and ensure consistent consumption performance
• Multi-species compatibility options allowing simultaneous behavioral management across different pet types without formulation development
• Enhanced bioavailability features, targeting specific stress pathways while preserving normal pet functions
• Improved compliance profiles enabling convenient dosing schedules and enhanced treatment adherence requirements

By Pet Type, the Dog Segment Accounts for the Largest Market Share

Dog applications dominate the pet type segment with approximately 65% market share in 2025, reflecting the critical role of canine behavioral management in supporting global pet ownership activities and anxiety treatment operations worldwide. The dog segment's market leadership is reinforced by increasing research and development in canine stress mechanisms, behavioral therapy advances, and rising requirements for breed-specific solutions in comprehensive pet care programs across developed and emerging markets.

The cat segment represents the second-largest pet type category, capturing 30.0% market share through specialized feline formulations for targeted stress control, environmental adaptation compounds, and behavioral modification applications. This segment benefits from growing pet owner preference for species-specific products that meet particular behavioral requirements, safety standards, and regulatory protocols in competitive pet care markets.

The others segment accounts for 5.0% market share, serving specialized applications including exotic pets, small mammals, and specialized companion animals across various pet care sectors.

Key market dynamics supporting pet type growth include:

• Dog segment expansion driven by behavioral research advances and canine wellness development, requiring specialized manufacturing facilities in emerging markets
• Cat segment modernization trends require high-quality, species-specific formulations for efficacy consistency and safety compliance
• Integration of multi-species technologies enabling precision behavioral management and monitoring systems
• Growing emphasis on pet type diversity driving demand for comprehensive, specialized wellness solutions

By Channel, the Online Segment Accounts for the Largest Market Share

Online channels dominate the distribution segment with approximately 60% market share in 2025, reflecting the critical role of e-commerce platforms in supporting global pet product accessibility and convenient purchasing operations worldwide. The online segment's market leadership is reinforced by increasing consumer preference for convenient shopping, product comparison capabilities, and rising requirements for subscription delivery in integrated pet care programs across developed and emerging digital markets.

The retail segment represents the traditional distribution category, capturing 40.0% market share through specialized pet store facilities for targeted product consultation, veterinary clinic partnerships, and professional recommendation services. This segment benefits from growing consumer preference for professional guidance that meets specific product requirements, safety assurance, and consultation protocols in competitive retail markets.

Key market dynamics supporting channel growth include:

• Online expansion driven by digital commerce advances and platform development, requiring specialized logistics facilities in emerging markets
• Retail modernization trends require high-quality, professional consultation for product consistency and customer education
• Integration of omnichannel technologies enabling precision customer targeting and inventory systems
• Growing emphasis on channel diversity driving demand for comprehensive, multi-platform distribution solutions

What are the Drivers, Restraints, and Key Trends of the Pet Relaxants Market?

The market is driven by three concrete demand factors tied to advanced pet wellness outcomes. First, increasing pet ownership rates and growing awareness of pet mental health create increasing demand for natural calming solutions, with pet ownership expanding by 6-10% annually in major developed regions worldwide, requiring comprehensive behavioral management infrastructure. Second, rising veterinary costs and preference for natural alternatives drive increased adoption of non-pharmaceutical relaxation products, with many pet owners implementing comprehensive wellness approaches for anxiety prevention by 2030. Third, technological advancements in natural ingredient extraction and formulation science enable more effective and cost-competitive relaxant solutions that reduce behavioral problems while improving pet comfort and stress management capabilities.

Market restraints include high research and development costs for novel formulations that can deter new market entrants from developing comprehensive product capabilities, particularly in developing regions where funding for ingredient research remains limited. Regulatory complexity and safety testing requirements pose another significant challenge, as pet supplement products demand extensive efficacy documentation and safety studies, potentially causing increased development costs and market entry delays. Pet owner education and product awareness requirements across different regions create additional operational challenges for product adoption, demanding ongoing investment in consumer education and veterinary professional training programs.

Key trends indicate accelerated adoption in Asia-Pacific markets, particularly China and India, where growing pet ownership and increasing disposable income drive comprehensive pet wellness product adoption. Technology integration trends toward precision formulation systems with targeted ingredient delivery, behavioral assessment tools, and integrated monitoring solutions enable proactive pet care approaches that optimize treatment outcomes and minimize behavioral episodes. However, the market thesis could face disruption if significant advances in pharmaceutical alternatives or major changes in pet care approaches reduce reliance on natural supplement technologies.

Analysis of the Pet Relaxants Market by Key Country

Country	CAGR (2025-2035)
India	5.0%
USA	4.8%
China	4.5%
UK	4.2%
Germany	4.0%
South Korea	3.8%
Japan	3.5%

The pet relaxants market is expanding steadily, with India leading at a 5.0% CAGR through 2035, driven by growing pet ownership, increasing disposable income, and rising awareness of pet wellness solutions. USA follows at 4.8%, supported by advanced pet care culture and premium product adoption. China records 4.5%, reflecting rising urban pet ownership in metropolitan centers. UK grows at 4.2%, maintaining leadership in natural pet care and veterinary guidance. Germany posts 4.0%, anchored by premium pet wellness facilities and regulatory compliance programs. South Korea advances at 3.8%, emphasizing technology integration, while Japan grows steadily at 3.5%, focusing on specialized pet care standards.

India Leads Global Market Expansion

India demonstrates the strongest growth potential in the pet relaxants market with a CAGR of 5.0% through 2035. The country's leadership position stems from rapid urbanization driving pet ownership growth, increasing disposable income among middle-class families, and growing pet care awareness driving the adoption of wellness solutions. Growth is concentrated in major metropolitan centers, including Mumbai, Delhi, Bangalore, and Chennai, where pet ownership rates and specialized pet care services are implementing natural wellness products for enhanced pet behavioral management and stress reduction. Distribution channels through e-commerce platforms and specialty pet stores expand deployment across urban pet owners and veterinary clinic networks. The country's emerging pet care industry provides policy support for natural wellness product adoption.

Key market factors:

• Pet ownership expansion concentrated in urban centers and metropolitan zones with comprehensive pet care development programs
• Rising income levels supporting premium pet wellness product adoption through specialized retail networks
• Comprehensive e-commerce ecosystem, including established online platforms with proven pet product distribution
• Growing awareness featuring veterinary education programs, pet care communities, and wellness optimization technologies

USA Emerges as Mature High-Growth Market

In New York, Los Angeles, Chicago, and Houston, the adoption of comprehensive pet relaxation solutions is accelerating across veterinary networks and specialty pet care facilities, driven by advanced pet care culture and premium wellness product preferences. The market demonstrates strong growth momentum with a CAGR of 4.8% through 2035, linked to comprehensive pet healthcare modernization and increasing focus on preventive behavioral management solutions. American pet owners are implementing advanced natural wellness systems and integrated behavioral management platforms to enhance pet comfort while meeting growing demand in expanding veterinary services and premium pet care sectors. The country's established pet industry creates persistent demand for innovative wellness solutions, while increasing emphasis on natural alternatives drives adoption of non-pharmaceutical relaxation systems.

Key development areas:

• Veterinary facilities and pet specialty centers leading natural wellness adoption with comprehensive behavioral management programs
• Premium pet care channels providing integrated solutions with 90% customer satisfaction improvement rates
• Technology partnerships between supplement companies and veterinary enterprises are expanding market reach
• Integration of advanced behavioral assessment technologies and comprehensive pet wellness management systems

China Shows Strong Regional Leadership

China's market expansion is driven by diverse urban pet ownership demand, including specialized pet care centers in Beijing and Shanghai, and comprehensive pet wellness adoption across multiple provinces. The country demonstrates promising growth potential with a CAGR of 4.5% through 2035, supported by government policy support for pet industry development and urban-level pet care infrastructure initiatives. Chinese pet owners face implementation challenges related to product awareness constraints and veterinary guidance availability, requiring phased education approaches and support from international manufacturers. However, growing pet ownership rates and urbanization trends create compelling adoption cases for relaxant products, particularly in metropolitan areas where pet behavioral management has a direct impact on urban living quality.

Market characteristics:

• Specialized pet care and wellness segments showing fastest growth with 20% annual increase in natural product utilization
• Regional expansion trends focused on tier-1 and tier-2 cities in eastern and southern provinces
• Future projections indicate the need for local veterinary education infrastructure and pet care specialist training programs
• Growing emphasis on pet wellness competitiveness in urban living environments

UK Demonstrates Premium Market Innovation

The UK market leads in advanced natural pet care innovation based on integration with veterinary behavioral systems and specialized wellness technologies for enhanced treatment performance. The country shows strong potential with a CAGR of 4.2% through 2035, driven by the modernization of existing pet care infrastructure and the expansion of specialized wellness facilities in major metropolitan centers, including London, Manchester, Birmingham, and Edinburgh. British pet owners are adopting intelligent wellness systems for behavioral management and anxiety prevention, particularly in regions with advanced veterinary requirements and specialized applications demanding comprehensive pet care upgrades. Distribution channels through established veterinary practices and premium pet retailers expand coverage across pet care facilities and wellness-focused consumers.

Leading market segments:

• Specialized veterinary modernization projects in major metropolitan centers are implementing comprehensive wellness upgrades
• Veterinary partnerships with wellness providers, achieving 95% treatment satisfaction improvement rates
• Strategic collaborations between natural product companies and veterinary operations are expanding market presence
• Focus on evidence-based systems and specialized behavioral requirements

Germany Emphasizes Quality and Compliance

In major pet care centers including Berlin, Munich, Hamburg, and Frankfurt, pet wellness facilities are implementing comprehensive natural relaxation solutions to modernize existing behavioral management infrastructure and improve treatment accuracy, with documented case studies showing a 30% improvement in anxiety management outcomes through advanced natural systems. The market shows strong growth potential with a CAGR of 4.0% through 2035, linked to the ongoing modernization of veterinary facilities, pet care networks, and emerging specialized wellness services in major regions. German pet owners are adopting intelligent wellness and monitoring platforms to enhance treatment reliability while maintaining quality standards demanded by regulatory authorities and veterinary professionals. The country's established pet care infrastructure creates persistent demand for system upgrade and modernization solutions that integrate with existing veterinary systems.

Market development factors:

• Veterinary facilities and pet wellness networks leading natural product modernization initiatives across Germany
• Pet care modernization programs providing regulatory framework support for wellness and veterinary infrastructure upgrades
• Strategic partnerships between German pet companies and international wellness providers are expanding technical capabilities
• Emphasis on evidence-based practices and quality standards compliance across pet care applications

South Korea Shows Technology-Driven Growth

South Korea's pet relaxants market demonstrates sophisticated implementation focused on advanced pet care technology and wellness optimization, with documented integration of smart wellness systems, achieving 35% improvement in behavioral management outcomes across veterinary and pet care facilities. The country maintains steady growth momentum with a CAGR of 3.8% through 2035, driven by pet care facilities' emphasis on innovation and continuous improvement methodologies that align with international pet wellness standards applied to urban pet ownership. Major metropolitan areas, including Seoul, Busan, Incheon, and Daegu, showcase advanced deployment of wellness platforms where pet care systems integrate seamlessly with existing veterinary management systems and comprehensive behavioral monitoring programs.

Key market characteristics:

• Pet care facilities and wellness centers are driving advanced natural product requirements with emphasis on innovation and quality
• Quality management partnerships enabling 98% treatment compliance with comprehensive monitoring programs
• Technology collaboration between Korean companies and international wellness providers is expanding market capabilities
• Emphasis on pet care innovation and continuous improvement methodologies

Japan Emphasizes Advanced Pet Care Integration

Japan's pet relaxants market demonstrates mature and quality-focused landscape, characterized by sophisticated integration of wellness systems with existing veterinary infrastructure across pet care facilities, veterinary networks, and specialized wellness initiatives. Japan's emphasis on advanced pet care practices and wellness standards drives demand for high-reliability natural products that support comprehensive pet care initiatives and regulatory compliance requirements in veterinary operations. The market benefits from strong partnerships between international wellness providers and domestic pet care leaders, creating comprehensive service ecosystems that prioritize product performance and veterinary training programs. Pet care centers in major metropolitan regions showcase advanced wellness implementations where natural product systems achieve 92% efficacy through integrated monitoring programs.

In Japan, the chews segment maintains market leadership with 55.0% share, driven by cultural preferences for convenient administration and established pet care practices. The drops segment captures 30.0% market share, while tablets applications account for 15.0%, reflecting the country's focus on specialized delivery solutions for diverse behavioral requirements.

Europe Market Split by Country

The pet relaxants market in Europe is projected to grow from USD 160.0 million in Germany in 2025, maintaining a 23.5% market share, supported by its extensive specialized veterinary infrastructure, advanced pet wellness facilities, and comprehensive natural product networks serving major European markets.

The UK follows with USD 110.0 million and a 16.2% share in 2025, driven by comprehensive pet care programs in major metropolitan regions implementing advanced wellness management systems. France holds USD 90.0 million with a 13.2% share through the ongoing development of specialized veterinary facilities and advanced pet wellness networks. Italy commands USD 70.0 million with a 10.3% share, while Spain accounts for USD 60.0 million with an 8.8% share in 2025. The Rest of Europe region maintains USD 190.0 million with a 27.9% collective share, attributed to increasing natural wellness adoption in Nordic regions and emerging Eastern European pet care facilities implementing advanced wellness programs.

Competitive Landscape of the Pet Relaxants Market

The pet relaxants market features approximately 15-18 meaningful players with moderate concentration, where the top three companies control roughly 25-35% of global market share through established natural wellness product portfolios and extensive veterinary industry relationships. Competition centers on product efficacy, safety profiles, and ingredient innovation rather than price competition alone.

Market leaders include Zesty Paws, Pet Naturals, and Vetoquinol, which maintain competitive advantages through comprehensive natural wellness solution portfolios, global distribution networks, and deep expertise in the veterinary and specialized pet care sectors, creating high switching costs for customers. These companies leverage established veterinary relationships and ongoing professional education services to defend market positions while expanding into adjacent wellness and integrated pet care applications.

Zesty Paws commands approximately 13.0% market share through advanced natural formulations and comprehensive marketing support services, establishing strong market presence across dog, cat, and specialty pet applications.

Challengers encompass Nestlé Purina and Nutramax, which compete through specialized wellness formulations and strong brand presence in key pet care markets. Wellness specialists, including VetriScience, Bark&Spark, and Thorne Pets, focus on specific ingredient technologies or specialized applications, offering differentiated capabilities in herbal treatments, delivery innovation, and application-specific solutions.

Regional players and emerging wellness companies create competitive pressure through innovative formulations and rapid market deployment capabilities, particularly in high-growth markets including India and China, where local presence provides advantages in consumer education and regulatory compliance. Market dynamics favor companies that combine advanced natural technologies with comprehensive professional services that address the complete pet wellness lifecycle from product development through ongoing veterinary support and behavioral management.

Global Pet Relaxants Market - Stakeholder Contribution Framework

Natural wellness solutions represent a critical pet care technology that enables pet owners, veterinary professionals, and animal care institutions to enhance behavioral management accuracy and treatment effectiveness without substantial pharmaceutical requirements, typically providing 80-90% efficacy rates comparable to traditional alternatives while improving pet comfort outcomes. With the market projected to grow from USD 760 million in 2025 to USD 1,200 million by 2035 at a 4.7% CAGR, these solutions offer compelling advantages - superior safety profiles, enhanced behavioral outcomes, and natural ingredient benefits - making them essential for preventive pet care practices (growing segment), comprehensive wellness operations (expanding adoption), and diverse pet applications seeking reliable calming solutions. Scaling market penetration and wellness capabilities requires coordinated action across veterinary policy, industry standards, natural product manufacturers, wellness technology providers, and research institutions.

How Governments Could Spur Local Production and Adoption?

• Pet Wellness Development Programs: Include natural wellness capabilities in national pet care development initiatives, providing targeted funding for specialized manufacturing facilities in underserved regions and supporting local wellness companies through innovation grants and development support.
• Tax Policy & R&D Support: Implement accelerated depreciation schedules for natural product manufacturing equipment, provide tax incentives for companies investing in advanced formulation and research technologies, and establish favorable research accounting standards that encourage natural wellness adoption over pharmaceutical approaches.
• Regulatory Framework Development: Create streamlined natural product registration processes across specialized and general pet applications, establish clear safety testing frameworks for wellness product operation, and develop international harmonization protocols that facilitate cross-border wellness trade.
• Skills Development & Training: Fund veterinary programs for wellness technicians, pet care specialists, and behavioral professionals. Invest in technology transfer initiatives that bridge academic research with commercial wellness development and pet behavioral optimization systems.
• Market Access & Competition: Establish procurement policies that favor natural wellness solutions for government animal care applications, support small and medium pet enterprises through preferential lending programs, and create regulatory environments that encourage innovation in wellness technologies.

How Industry Bodies Could Support Market Development?

• Efficacy Standards & Certification: Define standardized performance metrics for wellness systems across specialized, general, and integrated pet applications, establish universal safety and efficacy protocols, and create certification programs for product performance that veterinary professionals can rely on.
• Market Education & Best Practices: Lead messaging that demonstrates natural wellness advantages, emphasizing improved behavioral outcomes, enhanced pet comfort, and superior safety compatibility compared to pharmaceutical alternatives.
• Technology Integration Standards: Develop interoperability standards for wellness systems, comprehensive veterinary compatibility guidelines, and advanced pet care platforms, ensuring seamless integration across different pet care environments and behavioral requirements.
• Professional Development: Run certification programs for veterinary practitioners, wellness specialists, and technical service teams on optimizing natural product performance, behavioral management, and advanced pet care in competitive wellness markets.

How Manufacturers and Technology Players Could Strengthen the Ecosystem?

• Advanced Formulation Development: Develop next-generation natural products with enhanced efficacy capabilities, improved ingredient stability, and application-specific wellness features that enhance behavioral reliability while improving pet outcomes.
• Intelligence Platforms: Provide comprehensive wellness software that integrates behavioral monitoring, dosing optimization, predictive modeling, and performance optimization, enabling pet owners to maximize product effectiveness and treatment efficiency.
• Service & Support Networks: Offer flexible support programs for veterinary operations and pet care professionals, including technical training options, behavioral consultation services, and efficacy optimization pathways that keep wellness systems current with pet care demands.
• Research & Development Networks: Build comprehensive R&D capabilities, collaborative wellness innovation programs, and behavioral development systems that ensure natural technologies maintain high efficacy rates and consistent performance across diverse pet environments.

Key Players in the Pet Relaxants Market

• Zesty Paws
• Pet Naturals
• Vetoquinol
• Nestlé Purina
• Nutramax
• VetriScience
• Bark&Spark
• Thorne Pets
• Pet Wellbeing
• Virbac
• Ark Naturals
• PetNC
• Honest Paws
• Zoetis
• Calm Paws

Scope of the Report

Items	Values
Quantitative Units (2025)	USD 760 million
Form	Chews, Drops/Sprays, Tablets
Pet Type	Dog, Cat, Others
Channel	Online, Retail
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Countries Covered	USA, China, Germany, Japan, India, South Korea, UK, and 40+ countries
Key Companies Profiled	Zesty Paws, Pet Naturals, Vetoquinol, Nestlé Purina, Nutramax, VetriScience, Bark&Spark, Thorne Pets, Pet Wellbeing, Virbac, Ark Naturals, PetNC, Honest Paws, Zoetis, Calm Paws
Additional Attributes	Dollar sales by form and pet type categories, regional adoption trends across North America, Europe, and Asia Pacific, competitive landscape with wellness solution providers and veterinary companies, pet care facility requirements and specifications, integration with advanced veterinary initiatives and specialized wellness platforms.

Pet Relaxants Market by Segments

Form:

• Chews
• Drops/Sprays
• Tablets

Pet Type:

• Dog
• Cat
• Others

Channel:

• Online
• Retail

Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Nordic
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• Japan
• South Korea
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Latin America
• Brazil
• Chile
• Rest of Latin America
• Middle East & Africa
• Kingdom of Saudi Arabia
• Other GCC Countries
• Turkey
• South Africa
• Other African Union
• Rest of Middle East & Africa